Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
REMEDENT, INC.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
REMEDENT, INC.Listing unverified | Buy | $72.5K | conv 83First in 12mo | SEC | |
REMEDENT, INC.Listing unverified | Buy | $72.5K | conv 70First in 12mo | SEC | |
REMEDENT, INC.Listing unverified | BuyD (derivative) | n/a (No price was disclosed in the filing) | First in 12mo | SEC | |
REMEDENT, INC.Listing unverified | Buy | $80B | conv 58Cluster | SEC | |
REMEDENT, INC.Listing unverified | BuyD (derivative) | n/a (No price was disclosed in the filing) | Cluster | SEC | |
REMEDENT, INC.Listing unverified | Buy | $44.6B | conv 35 | SEC |